The Globe and Mail reports in its Friday, Jan. 5, edition that Scotia Capital analyst George Doumet has resumed coverage on Dentalcorp Holdings with a "sector outperform" recommendation, seeing its shares as "down, but not out." The Globe's David Leeder writes in the Eye On Equities column that Mr. Doumet set a share target of $8.50. Analysts on average target Dentalcorp shares at $10.30. Mr. Doumet says in a note: "Dentalcorp shares are down approximately 50 per cent since its IPO (in 2021), despite growing adj. EBITDA by 32 per cent and FCF by 75 per cent. During this time, balance sheet leverage has remained largely unchanged. While the underperformance is partly attributable to fundamentals (labour and other cost pressures, etc.), we believe external factors played a disproportional role in the decline of the shares. Fast-forward to today, we believe we can see significant upside in the shares under a soft landing scenario (where rates continue to deflate). Dentalcorp shares are trading at a 40-per-cent discount to U.S. consolidators/practice aggregators peers and 10-per-cent discount to Canadian non-cyclical roll-up peers. ... Applying an average historical valuation points to an 90-per-cent upside."